Showing results (1-10 of 85) with videos related to
Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2024
Project Optimus Elicits the "Holistic" Benefits of PK/PD Modeling of ImmunotherapyMathangi Gopalakrishnan, Rodabe N AmariaTherapeutic Advances in Medical Oncology|March 1, 2019
Combined targeted therapy and immunotherapy in melanoma: a review of the impact on the tumor microenvironment and outcomes of early clinical trialsMeredith S Pelster, Rodabe N AmariaAmerican Journal of Clinical Dermatology|July 25, 2018
Challenges and Opportunities of Neoadjuvant Treatment in Locally Advanced MelanomaMeredith A McKean, Rodabe N AmariaExpert Opinion on Pharmacotherapy|April 12, 2014
Dabrafenib for the treatment of melanomaRodabe N Amaria, Kevin B KimCurrent Treatment Options in Oncology|February 7, 2020
Neoadjuvant Immunotherapy for Locally Advanced MelanomaMeredith S Pelster, Rodabe N AmariaCancer Treatment Reviews|September 10, 2018
Multidisciplinary treatment strategies in high-risk resectable melanoma: Role of adjuvant and neoadjuvant therapyMeredith A McKean, Rodabe N AmariaTherapeutic Advances in Medical Oncology|September 30, 2011
Therapeutic options in cutaneous melanoma: latest developmentsRodabe N Amaria, Karl D Lewis, Rene GonzalezOncoimmunology|May 6, 2015
Evidence of synergy with combined BRAF-targeted therapy and immune checkpoint blockade for metastatic melanomaZachary A Cooper, Alexandre Reuben, Rodabe N Amaria, et al.Immunotargets and Therapy|July 30, 2016
Update on use of aldesleukin for treatment of high-risk metastatic melanomaRodabe N Amaria, Alexandre Reuben, Zachary A Cooper, et al.Journal of Pigmentary Disorders|December 19, 2017
RAF Inhibitor Therapy Promotes Melanocytic Antigen Expression and Enhanced Anti-Tumor Immunity in MelanomaAlexandre Reuben, Rodabe N Amaria, Zachary A Cooper, et al.Pageof 9